A med spa’s value depends on sustainable earnings, the labor and capital needed to maintain them, and the risk of transferring the business to a buyer. Calculate SDE or adjusted EBITDA consistently, verify the supporting records, then evaluate price alongside financing, membership obligations, provider continuity, taxes, and payment terms.
Which earnings measure fits the business?
Choose the measure that matches the operating model and buyer. Seller’s discretionary earnings is an owner-operator earnings measure that commonly incorporates one working owner’s compensation and supported discretionary adjustments. Its exact calculation should be stated. Adjusted EBITDA starts with earnings before interest, taxes, depreciation, and amortization, then applies justified normalization adjustments.
The distinction matters when the owner treats patients. Removing all owner pay without charging for replacement clinical labor can exaggerate earnings available to an investor. Conversely, presenting only manager-run EBITDA can obscure the economic benefit a qualified buyer expects from personally doing that work.
Prepare both bridges when buyer types differ, with explicit staffing assumptions. Do not multiply SDE by a multiple intended for a managed EBITDA business. State the period measured, accounting basis, services included, and whether rent and professional-entity costs are already reflected.
How do you normalize earnings without inflating them?
Begin with reported results and make adjustments traceable. A useful bridge contains the account, amount, explanation, supporting record, and ongoing treatment after closing. Keep favorable and unfavorable adjustments together. A nonrecurring legal expense may increase normalized earnings; below-market rent or missing clinical leadership compensation may reduce them.
One-time does not automatically mean removable. If equipment repairs recur on different devices each year, the business may need an ordinary maintenance allowance. If the owner stopped advertising during sale preparation, restoring a sustainable acquisition budget may be necessary to support revenue.
Evaluate treatment packages, memberships, gift cards, and deposits carefully. Collected cash can remain attached to a future service obligation. An accountant should determine appropriate recognition and reconciliation. Buyers should also test the cost of honoring those commitments and how they are handled in closing adjustments.
What does a transparent earnings bridge look like?
Consider an illustrative practice reporting $245,000 of net income. Add $38,000 interest, $24,000 depreciation, $12,000 amortization, and $21,000 entity-level income tax expense already deducted in that figure. Reported EBITDA is $340,000. If the accounts do not contain entity-level income tax expense, do not add personal income taxes instead.
Suppose documented nonrecurring legal work adds $18,000, while replacement management and clinical coverage require $63,000 above existing compensation. Adjusted EBITDA becomes $340,000 + $18,000 − $63,000 = $295,000. The $63,000 deduction is as important as the favorable add-back.
| Item | Amount |
|---|---|
| Reported net income | $245,000 |
| Interest, depreciation, amortization, entity tax | +$95,000 |
| Supported nonrecurring legal expense | +$18,000 |
| Additional replacement coverage | −$63,000 |
| Illustrative adjusted EBITDA | $295,000 |
These assumptions teach the mechanics. They are not a valuation opinion, verified compensation benchmark, or real client result.
How should a valuation multiple be selected?
A defensible multiple comes from relevant evidence and risk analysis. Ask whether the source describes closed transactions or asking prices, which period it covers, the earnings definition, business size, sample selection, and included consideration. A platform acquisition may incorporate management infrastructure and growth assumptions absent from a single-site practice.
The May 2026 AmSpa commentary by Tommy Newton of Xite describes 2025 valuation patterns by scale. It is a commercial advisor’s market observation rather than a fully disclosed transaction database. Treat it as directional context, with its date and limitations visible. Do not relabel historical observations as a guaranteed current offer.
At practice level, investigate provider concentration, owner dependence, patient retention, service margins, membership performance, compliance arrangements, lease stability, and reinvestment needs. These factors affect what a specific buyer can sustain. A premium claim needs evidence about the business, not only a statement that memberships or injectables are attractive.
How do price and sale proceeds differ?
Enterprise value describes the operating business under the agreed convention. Equity value reflects the adjustments needed to reach the owners’ interests. Immediate cash proceeds then reflect the payment mix, debt, costs, closing adjustments, and tax consequences. A sale headline often skips several of these steps.
For an illustrative $2.15 million enterprise value, subtract $275,000 funded debt and add $40,000 eligible excess cash, assuming the agreement uses that convention. Indicated equity value is $1.915 million before other adjustments. If $300,000 is a seller note and $150,000 is rollover equity, immediate gross cash is $1.465 million before expenses, escrows, and taxes.
Do not count the seller note at face value as spendable cash. Do not assume rollover equity can be sold on demand. Compare the contractual rights, security, payment priority, control, dilution provisions, and liquidity restrictions before choosing between economically different offers.
Where do memberships and equipment enter the calculation?
Memberships influence both the quality of earnings and the obligations delivered to a buyer. Recurring collections can support planning, but discounts, cancellations, failed payments, unused credits, and costly redemption patterns can weaken the result. Build member cohorts and a treatment-liability schedule rather than valuing the total member count alone.
Devices require separate review of title, debt, remaining useful service, utilization, consumables, and maintenance. Depreciation is an accounting expense; the eventual cash cost of replacement still matters to a buyer. Adding depreciation back does not make a capital-intensive practice free of reinvestment needs.
Supplier legitimacy also belongs in earnings quality. The FDA counterfeit Botox alert from April 2024 provides a reason to verify purchasing channels. A margin based on an unsupported product source should not be capitalized as durable profit. Document the cost of compliant replacement supply and any necessary remediation.
How does financing limit an affordable purchase price?
A buyer must fund the acquisition and operate afterward. Debt service competes with provider compensation, rent, inventory, capital investment, and owner distributions. Model debt using the proposed rate, amortization, fees, and any balloon, then test a lower-earnings scenario rather than relying only on the lender’s maximum proceeds.
The SBA 7(a) program overview identifies business ownership changes as a permitted use and sets the standard maximum loan amount at $5 million. Eligibility, lender underwriting, repayment ability, equity, and structure remain separate requirements. A program maximum is not an appraisal or a commitment to finance a med spa.
Ask a lender to evaluate the transaction early enough to influence the letter of intent. Obtain current requirements for the buyer’s ownership arrangement, seller financing, guarantees, and working capital. A price acceptable to seller and buyer can still fail if the proposed capital structure is not financeable.
How do you present uncertainty without losing usefulness?
Use sensitivities that explain a decision. Show the change in sustainable earnings if replacement coverage costs more, member redemptions rise, or a key provider’s production falls. Keep each assumption separate so the reader can identify what causes the result. A wide range with transparent drivers is more useful than an exact price built on hidden guesses.
Document the conditions under which you would revise the analysis. Updated financial statements, signed retention arrangements, lender feedback, and verified contract changes may justify a different conclusion. Merely changing the date on the document does not. Maintain the original version and a brief change log so buyer, seller, and advisors can trace why the valuation discussion moved.
How should taxes and legal structure be incorporated?
Model taxes before signing away negotiating flexibility. The IRS guidance on selling a business explains that a lump-sum asset transaction generally involves separate assets and allocation, with different tax treatment possible. Entity structure, basis, depreciation history, state rules, and contingent consideration can materially alter proceeds.
Ask the CPA to model the actual proposed transaction rather than applying a universal tax rate. Ask healthcare counsel whether the business and professional entities need separate transfers or agreements. These specialists should coordinate so the purchase allocation reflects what legally changes hands.
Build a valuation file with the earnings bridge, source documents, market evidence, sensitivity analysis, and offer comparison. Start with the seller planning hub or buyer acquisition hub, then connect the assumptions to operating improvements and the market evidence discussion.
What should you read next?
Explore the detailed resources in this section as your questions become more specific.
- How do you build a monthly cash budget for a med spa acquisition?
- Adjusted EBITDA for a Med Spa
- Illustrative $2 million laser center sale: aging equipment and cash flow
- Cash-Pay Percentage in a Med Spa
- Deferred Membership Revenue in a Med Spa
- Device financing and med spa cash flow: bridge earnings to the obligations that must be paid
- Device Leases and Service Contracts in Med Spa Deals
- Illustrative med spa sale with financed devices and lien payoffs
- Device Vintage and Replacement Capex in a Med Spa
- Earnouts in Med Spa Transactions
- How do you make a med spa earnout calculation auditable?
- Earnout vs. rollover equity in a med spa sale: risk, control, and cash
- When does a med spa equipment appraisal help a business valuation?
- The Four-Number Med Spa Valuation Screen
- Gift-card breakage in a med spa sale: separate accounting estimates from patient rights
- Illustrative med spa valuation with concentrated provider revenue
- Indemnity Escrow in a Med Spa Sale
- Injectables-led vs. device-heavy med spas: how buyers test value
- Med spa acquisition lender-document checklist: current SBA context
- Add-Backs in Med Spa Earnings
- Med spa add-backs: which earnings adjustments can survive buyer review?
- Quality of earnings for a med spa: what the buyer’s accountant should test
- How interest rates and PE fundraising affect med spa valuation decisions
- Rollover equity in an aesthetics platform: evaluate the investment behind the second bite
- Taxes on selling a med spa: plan allocation, structure, and cash timing early
- Med spa valuation multiples: SDE, EBITDA, and what the numbers mean
- Valuing wellness, IV, and hormone services inside a med spa: isolate the business economics
- Working capital pegs in med spa deals: define the accounts before the number
- Med spa memberships: recurring revenue, deferred obligations, and deal math
- Illustrative $3.5 million injectables med spa: a membership PE offer
- How do you consolidate MSO and professional-entity financials?
- The Offer-to-Proceeds Bridge for Med Spa Sellers
- Owner-injector vs. employed-injector med spas: valuation and transition
- How do price, volume, and service mix explain med spa growth?
- Quality of Earnings for a Med Spa
- Related-party rent in a med spa valuation: separate the practice from the property return
- Representations and Warranties Insurance in Med Spa Deals
- Rollover Equity in a Med Spa Sale
- SBA 7(a), seller financing, or PE capital for a med spa acquisition?
- Illustrative seasonal med spa sale and working-capital adjustment
- Seller’s Discretionary Earnings for a Med Spa
- Illustrative $900,000 med spa sale: the owner-injector earnings problem
- Supplier rebates in med spa earnings: trace eligibility, timing, and transferability
- Tips, payroll, and med spa revenue: reconcile patient payments before valuing earnings
- Working Capital Peg in a Med Spa Sale
What else do owners and buyers ask?
Can I use revenue to estimate my med spa’s value?
Revenue is a useful scale measure, but it does not show what the business retains after products, providers, rent, oversight, and marketing. Two equally sized practices can produce very different earnings. Use revenue to organize the analysis, then evaluate verified cash flow, required staffing, obligations, and risk before discussing a price.
Are owner salary and owner profit the same thing?
No. Clinical and management work have an economic cost even when the owner performs them. A buyer who personally fills the role may receive both labor income and investment return. A buyer hiring replacements must fund those positions. State the assumption clearly so an earnings measure does not hide unpaid work.
Does a buyer have to accept my add-backs?
No. Buyers and lenders can challenge adjustments and require evidence that the expense will disappear without damaging operations. Keep invoices and explanations for each item. Expect scrutiny of family payroll, travel, marketing, repairs, and owner compensation, and show any offsetting costs required by the buyer’s operating plan.
Can I know my exact after-tax proceeds before an offer?
You can build scenarios, but exact proceeds depend on the final price, payment mix, debt, fees, tax basis, allocation, and adjustments. Your CPA can identify the most important sensitivities early. Update the model when terms change, particularly for seller notes, earnouts, retained equity, and assets with depreciation history.
Which sources support this guide?
Sources were checked during research. Regulations, lender policies, and market conditions can change. Use the linked primary material and your advisors to confirm applicability.
- 2025 med spa M&A observations, published May 2026 — American Med Spa Association / Tommy Newton, Xite
- Counterfeit version of Botox found in multiple states — U.S. Food and Drug Administration
- 7(a) loans and changes of ownership — U.S. Small Business Administration
- Sale of a business — Internal Revenue Service
Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.